Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

» Details

Guru Trades

Q1 2016

XBI Guru Trades in Q1 2016

First Eagle Investment 18,150 sh (New)
» More
Q2 2016

XBI Guru Trades in Q2 2016

Steven Cohen 191,000 sh (New)
First Eagle Investment 18,150 sh (unchged)
» More
Q3 2016

XBI Guru Trades in Q3 2016

Louis Moore Bacon 100,000 sh (unchged)
First Eagle Investment Sold Out
Steven Cohen 152,500 sh (-20.16%)
» More
Q4 2016

XBI Guru Trades in Q4 2016

Paul Tudor Jones 325,000 sh (New)
Steven Cohen 63,500 sh (-58.36%)
» More

Ratios

vs
industry
vs
history
PB Ratio 5.77
XBI's PB Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XBI: 5.77 )
Ranked among companies with meaningful PB Ratio only.
XBI' s PB Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 5.83
Current: 5.77
0
5.83

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.17
XBI's Dividend Yield % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XBI: 0.17 )
Ranked among companies with meaningful Dividend Yield % only.
XBI' s Dividend Yield % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.52
Current: 0.17
0
0.52
5-Year Yield-on-Cost % 0.17
XBI's 5-Year Yield-on-Cost % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XBI: 0.17 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
XBI' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.52
Current: 0.17
0
0.52

More Statistics

Short Percentage of Float0.00%
52-Week Range $49.55 - 72.32
Shares Outstanding (Mil)44,950,000.00
» More Articles for XBI

Headlines

Articles On GuruFocus.com
Intel Increases Quarterly Dividend Mar 29 2017 
Joel Greenblatt Dividend Stocks in Focus: The Gap Mar 29 2017 
Is IBM a Better Dividend Play Than Microsoft? Mar 29 2017 
Amazon Furiously Future-proofing Itself in Multiple Industry Segments Mar 29 2017 
Facebook Will Continue to Excel Mar 29 2017 
David Einhorn Discusses Plan to Unlock Value at General Motors Mar 29 2017 
David Einhorn to CNBC: Invest Here Instead of Infrastructure for Trump Presidency Mar 29 2017 
Insiders Invest in National General Holdings Mar 29 2017 
Insiders Invest in Ryerson Holding Mar 29 2017 
GMO - The 100 Year: A Take on the Century Bond Mar 29 2017 

More From Other Websites
5 ways to trade today's market rally Mar 28 2017
Biotech ETFs Defy Trump Tweets To Rally, But What Can Send Them Higher? Mar 28 2017
Tax reform could be a back door for another Republican Obamacare repeal attempt Mar 28 2017
What Trump can do to undermine Obamacare, now that the GOP health bill has failed Mar 27 2017
Trump Pulls the Healthcare Bill; Market Feels the Pain Mar 24 2017
Recent Developments for Ionis Pharmaceuticals Mar 22 2017
Biotechnology Gets A Shot In the Arm Mar 21 2017
Understanding Ionis Pharmaceuticals’ 2016 Revenue Stream Mar 21 2017
Biotech firm says it’s closing in on the cancer that killed Steve Jobs Mar 20 2017
Biogen Weighs On Biotech ETFs; Time to Bail? Mar 16 2017
Wednesday’s Biggest Biopharma Movers Mar 15 2017
Time to Buy Biotech ETF? Mar 13 2017
Time to Buy Biotech ETFs? Mar 13 2017
Trump Expected to Name Scott Gottlieb as FDA Commissioner Mar 10 2017
Trump administration expected to name VC partner Gottlieb to head FDA Mar 10 2017
Adam Feuerstein Talks Vulnerable Pharmaceuticals, Drug Pricing Under Trump Mar 10 2017
These Health Care ETFs Could Be in Play with the GOP's ACA Repeal Mar 09 2017
Trump’s ‘Obamacare Lite’ presents opportunities and perils for investors Mar 09 2017
Stocks Fall for Day Two as Trump Targets Health Care Sector Mar 07 2017
Biotech: When @RealDonaldTrump Shows Up Mar 07 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK